M&A / Deals AstraZeneca, GSK intensify China ties with Sino Biopharm deals BioPharma DiveThe U.K.Read full story pharminent July 8, 2026 (Last updated: July 9, 2026) BioPharma Dive The U.K. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Novartis Pays $1.1B Upfront for Myricx Bio ADC PlatformNext: Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens Partnership With GSK Related Stories M&A / Deals Vertex buys Crinetics for $10bn in endocrinology drive pharminent July 7, 2026 M&A / Deals Novartis to acquire Myricx Bio in up to $1.5bn deal pharminent July 6, 2026 M&A / Deals Roche looks to Astex in $515m breast cancer deal pharminent July 6, 2026
